Top States
Aspire Infusions Top StatesApr 2026
Top states where Aspire Infusions is active based on indexed sales coverage.
Is this your Brand? Log in to Hoodie!
Aspire Infusions
Apr 2026
Overview
Welcome to ASPIRE, where people are at the heart of our journey. We believe in the power of empathy, growth, and collaboration, as we strive to become a household name synonymous with excellence in infused cannabis products. Our mission is to foster meaningful connections, provid...
ASPIRE INFUSIONS has achieved a remarkable YoY growth of 20.9%—now positioned in the premium tier at $250-500K. Monthly sales are up 16.7% over the last three months, reflecting a strong demand trajectory.
Categories
OralEdiblesConcentratesFlower
- Top Category: Oral
- Price Tier: Premium
- States Active: 1
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$29.26
YoY Sales Trend
20.9%
2Y Sales Trend
96.3%
Oral products dominate at 82.8% with a stellar YoY growth of 23.3%, leading all categories. Edibles follow at 10.5% with 21.5% growth, while Flower shows a solid 17.0% increase.
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 82.9% | $30.03 | 23.3% |
| Edibles | 10.5% | $26.56 | 21.5% |
| Concentrates | 4.0% | $22.13 | 2.6% |
| Flower | 2.6% | $32.25 | 17.0% |
Trend View
Market Insights SnapshotApr 2026
24-Month Trend
Average Price
$29.26
YoY Sales Trend
20.9%
2Y Sales Trend
96.3%
Category Breakout
| Category | Sales Share | Avg Price | YoY |
|---|---|---|---|
| Oral | 82.9% | $30.03 | 23.3% |
| Edibles | 10.5% | $26.56 | 21.5% |
| Concentrates | 4.0% | $22.13 | 2.6% |
| Flower | 2.6% | $32.25 | 17.0% |
State Rank Table
| State | Oral | Edibles | Concentrates | Flower |
|---|---|---|---|---|
| Ontario | 5 | 35 | ⊖ | ⊖ |
ASPIRE INFUSIONS holds a concentrated presence in Ontario, which accounts for 100% of sales. Currently, they are active in only one state.
| State | Oral | Edibles | Concentrates | Flower |
|---|---|---|---|---|
| 5 | 35 | ⊖ | ⊖ |
Market Position
Competitive LandscapeApr 2026
#3 in Oral, ASPIRE INFUSIONS trails behind BHANG (#1) and REDECAN (#2) while gaining on TWEED (#5). Competitive dynamics are tight in the oral segment.
SKU View
Top Selling ProductsApr 2026
Top products for Apr 2026 with sales and momentum indicators.
| Product | Category | MoM |
|---|---|---|
#1  | Concentrates | 359.9% |
#2 | Concentrates | 65.2% |
#3 ![Spark 1:1 Moonrocks [30pk] (300mg Cbd/300mg Thc)](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2Fa9cdcfad01032627d5f84f0318503006&w=64&q=75){kind=small} | Oral | 2.2% |
#4  | Edibles | 4.0% |
#5 ![Spark Moonrocks [15pk] (150mg)](/_next/image?url=https%3A%2F%2Fdata-item-images.s3.us-east-2.amazonaws.com%2Fsuccess%2Ff98f2562515c7e638469d53db5884807&w=64&q=75){kind=small} | Oral | 3.6% |
Benchmarking
Competitive Peer Set
Peer brands benchmarked against Aspire Infusions using competitive landscape rank coverage, proximity, and momentum.
